Health plan considerations for growing direct-to-consumer genetic testing

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Barbara Culley | 17 August 2017
The growth in direct-to-consumer (DTC) genetic testing is driven by consumer awareness of the links between genetics and diseases, the evolution of patient empowerment, and precision medicine. This white paper looks at the progression of DTC genetic testing and the current demand and growth, discusses industry concerns, and suggests activities for health plans to consider.